About Inventprise

Inventprise is leveraging its innovative platform technology to develop vaccines against infectious diseases with an initial focus on invasive pneumococcal disease.

About Inventprise

Inventprise platform technologies are designed to enable high valent vaccines to induce broad, robust, and durable protection against pathogenic strains of infectious diseases.

In addition to its lead candidate, the 25-valent pneumococcal conjugate vaccine, Inventprise has a robust pipeline of investigational vaccines including candidates to prevent group B streptococcus (GBS), Shigella and Klebsiella.

Inventprise was founded by Subhash Kapre, PhD in 2012 to advance novel, highly impactful vaccines using proprietary technology, with the initial goal of providing lifesaving interventions globally.

Our mission is to empower people to live healthy lives by inventing better vaccines.

We leverage the best of vaccine technology, science, and manufacturing to prevent infectious disease

Our Focus is On Science

Together with our community of collaborators, Inventprise engages in cutting-edge research bringing incisive scientific insights and novel products to global populations in need of important, life-saving vaccines.

Our efforts have led to over fifty patents, many on proprietary approaches and methods in the development of highly immunogenic vaccines.

With multiple partners and collaborations, and a large portfolio of vaccine candidates, our aim is to remain true to our science, continue to innovate and deliver better vaccines to the world.

Executive Leadership

INVENT_web_team_KapreDRAFT

Subhash Kapre, PhD
Executive Chairman & Founder

INVENT_web_team_LeurquinDRAFT

Yves Leurquin, Eng., MS
President & CEO

INVENT_web_team_Ghate

Pradip Ghate, MS, MBA
COO

INVENT_team_pix_-Tasker

Sybil Tasker, MD, MPH, FIDSA
CMO

INVENT_web_team_Goesling

Dave Goesling, MBA
CFO

Management Team

INVENT_web_team_Andi-LoloWHITE

Indah Andi-Lolo, MSc. PMP
VP Portfolio Management

INVENT_web_team_Datta

Anup Datta, PhD
VP Bacterial Vaccines

INVENT_web_team_Olave

Ivan Olave, PhD
VP Viral Vaccines

INVENT_web_team_silverberg

Mark Silverberg
VP Quality

INVENT_web_team_Cherian

Philip Cherian
VP Material Management & Engineering Innovations

INVENT_web_TeamPhotos_Kumar

Manoj Kumar, PhD
VP Manufacturing Science & Technology

INVENT_team_nu_ramesh-_5_23

Ramesh Shanbhag, PE. CEng.
VP Facility & Engineering

INVENT_web_team_KAPIL-KAPRE

Kapil Kapre
Director Project Management & Automation

INVENT_web_team_BEYER

Philip Beyer
Deputy Director Manufacturing

INVENT_team_Miller_FIN_pix

Amanda Miller
Director Human Resources

Board of Directors

Subhash Kapre, PhD
Chairman
Niranjan Bose, PhD
Co-Chairman
Ralf Clemens, MD, PhD
Director
H. Stewart Parker, MBA
Director
Donna Ambrosino, MD
Director
Yves Leurquin, Eng, MS
Director
Andrew Farnum
Director

Scientific Advisory Board

Christian Mandl, MD, PhD
SAB Chair
Subhash Kapre, PhD
Advisor
Ralf Clemens, MD, PhD
Advisor
Donna Ambrosino, MD
Advisor
Kathleen Neuzil, MD
Advisor
Peter Dull, MD
Advisor